Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study - Concepedia

Concepedia

Publication | Open Access

Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study

DOI Full Paper Access

20

Citations

21

References

2022

Year

Rafaella Fortini Queiroz Grenfell, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, Camila Amormino Corsini, Sarah Vieira Contin Gomes, Daniel Alvim Pena de Miranda, Adelina J. Lourenço, Olindo Assis Martins‐Filho, Jaquelline Germano de Oliveira, Andréa Teixeira‐Carvalho,

Frontiers in Immunology

Abstract

Fiocruz, Brazil.

References

	Year	Citations

Page 1